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Abstract
Background: Ankle fractures are common. Management of ankle fractures generally involves a period of
immobilisation followed by rehabilitation to reduce pain, stiffness, weakness and swelling. The effects of a
rehabilitation program are still unclear. However, it has been shown that important components of rehabilitation
programs may not confer additional benefits over exercise alone. The primary aim of this trial is to determine the
effectiveness and cost-effectiveness of an exercise-based rehabilitation program after ankle fracture, compared to
advice alone.
Methods/Design: A pragmatic randomised trial will be conducted. Participants will be 342 adults with stiff, painful
ankles after ankle fracture treated with immobilisation. They will be randomly allocated using a concealed
randomisation procedure to either an Advice or Rehabilitation group. Participants in the Advice group will receive
verbal and written advice about exercise at the time of removal of immobilisation. Participants in the Rehabilitation
group will be provided with a 4-week rehabilitation program that is designed, monitored and progressed by a
physiotherapist, in addition to verbal and written advice. Outcomes will be measured by a blinded assessor at 1, 3
and 6 months. The primary outcomes will be activity limitation and quality-adjusted life years.
Discussion: This pragmatic trial will determine if a rehabilitation program reduces activity limitation and improves
quality of life, compared to advice alone, after immobilisation for ankle fracture.
Background
Ankle fracture, fracture of the distal tibia and/or fibula,
is the second most common ankle injury after ankle
sprain [1]. The incidence of ankle fracture is at least 5
per 10,000 person-years across all ages [2,3], but is
higher in young men (13 to 28 per 10,000 person-years)
and older women (16 to 20 per 10,000 person-years).
The orthopaedic management depends on the severity
of the fracture, but generally involves immobilisation of
the ankle in a cast or a brace for about 6 weeks [4]. Sur-
gical fixation is required in about 50% of cases [5,6].
The disabling sequelae of ankle fracture and the sub-
sequent immobilisation frequently affect people’s ability
to return to work and sport. Our recent study showed
that people with ankle fracture had significant activity
limitation after the period of immobilisation (mean
Lower Extremity Functional Scale score of 33.6, where
no activity limitation receives a score of 80) and one-
third were unable to walk without crutches [5]. Impair-
ments include pain [5,6], stiffness [7,8], weakness [9-11]
and swelling [12,13]. Rehabilitation programs are often
provided to address these sequelae and can commence
as soon as the fracture has been stabilised (i.e. during
the period of immobilisation) or, more often, after the
period of immobilisation (i.e. when bone union has
occurred). Typically a post-immobilisation program con-
sists of stretch, manual therapy, exercise, gait training
and advice [5,6].
There is limited evidence on the effects of rehabilita-
tion interventions for ankle fracture. A Cochrane sys-
tematic review has evaluated the effects of rehabilitation
interventions applied during or after the period of
immobilisation. It concluded that commencing weight
bearing during the immobilisation period and wearing a
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brace that can be removed to allow gentle ankle exercise
may improve outcome after ankle fracture [14].
The Cochrane review identified only two randomised
controlled trials which investigated effects of rehabilita-
tion after the immobilisation period [6,15]. Two other
trials have been recently completed [5,16]. These trials
concluded that adding passive stretch or manual therapy
to an exercise program does not improve clinical or eco-
nomic outcomes compared to exercise alone [5,6,15],
and found no overall benefit of participating in an exer-
cise program [16]. However, in the trial that compared
an exercise program to usual care, benefits of the exer-
cise program could have been underestimated as there
was a high uptake of physiotherapy (a mean of 7 phy-
siotherapy appointments) by participants from the usual
care group [16]. In addition, the trial only included peo-
ple whose ankle had been treated surgically [16].
It is still unclear if some sub-groups could benefit
more from rehabilitation than others. Nilsson et al [16]
compared the effects of rehabilitation on Olerud-Molan-
der Ankle Score (range 0 to 100) in those aged < 40
years and those ≥ 40. There was no difference in effects
of rehabilitation at 6 months. However the effect of
rehabilitation at 12 months was greater in people aged <
40 than in those aged ≥ 40 (mean difference in effect
16.9 points, 95% CI 5.6 to 28.2). This finding should be
considered provisional until it is replicated in other stu-
dies. We postulate that participation in a rehabilitation
program may particularly benefit older women (aged
over 50 years) as they are more likely to suffer from
osteoporosis [17], and physical performance [18] and
physical activity [19] also decline with age. The severity
of fracture has also been found to influence outcome in
ankle fracture [20], which raises the idea that rehabilita-
tion should be offered selectively. In this case, it could
be argued that people with more severe fracture would
have worse outcomes and, consequently, would benefit
more from a rehabilitation program.
The prediction of outcome after ankle fracture is rela-
tively imprecise. We have previously shown that out of
eight variables, pain and dorsiflexion range of motion
soon after the period of immobilisation were the only
independent predictors of outcome, but explained only
9 to 12% of the variance in activity limitation in the
short- to medium-term [21]. Other variables (e.g. psy-
chological factors) may be better predictors of outcome
after ankle fracture. It has been shown that psychologi-
cal variables (including pain catastrophising and depres-
sion) appear to be important predictors of outcome in
people with other musculoskeletal conditions [22]. This
issue has not been examined after ankle fracture.
The primary aims of the trial to be conducted are,
therefore, to determine (a) the effectiveness and cost-
effectiveness of rehabilitation, compared to simple
advice and (b) if effects of rehabilitation are influenced
by fracture severity or by the age and gender of partici-
pants. A secondary aim is to identify predictors of out-
come after ankle fracture.
Methods/Design
The trial will be an assessor-blinded pragmatic rando-
mised controlled trial. Three hundred and forty two par-
ticipants will be randomly allocated to one of two
groups: an Advice group and a Rehabilitation group
(~171 in each group). Outcomes will be assessed at
baseline, 1, 3 and 6 months by a blinded assessor (Fig-
ure 1).
Participants
Participants will be recruited from four hospitals. The
inclusion criteria will be:
• ankle fracture treated with immobilisation (e.g. cast,
brace), with or without surgical fixation
• immobilisation removed on the day of recruitment
• approval received from orthopaedic specialist to
weight-bear as tolerated or partial weight-bear
• reduced ankle dorsiflexion range of motion (at least
30 mm less motion compared to the non-fractured leg
using the weight-bearing lunge method) [23]
• at least 2 out of 10 pain in the ankle when up to
50% of body weight is borne through the affected leg
• completed skeletal growth (i.e. no evidence of epi-
physeal cartilage in the tibia in x-rays taken for fracture
management)
• no concurrent pathologies (e.g. symptomatic osteoar-
thritis, stroke, other fractures) which affect the ability to
perform everyday tasks or the measurement procedures
used in this trial, and
• informed consent obtained.
Recruitment sites
Participants will be recruited from the fracture clinics of
four public hospitals in Sydney, Australia: Royal North
Figure 1 Experimental protocol.
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Shore Hospital, Prince of Wales Hospital, Royal Prince
Alfred Hospital and Ryde Hospital. Royal North Shore
Hospital, Prince of Wales Hospital and Royal Prince
Alfred Hospital are major teaching hospitals with more
than 500 beds. Ryde Hospital is a smaller teaching hos-
pital of close to 200 beds. At these hospitals the fracture
clinics are staffed by physiotherapists, who are responsi-
ble for the application and removal of immobilisation
and the provision of advice about rehabilitation after
orthopaedic clearance.
Randomisation
Randomisation will be conducted using a telephone-
based randomisation service provided by the Australian
National Health and Medical Research Council
(NHMRC) Clinical Trials Centre. This ensures conceal-
ment of the allocation schedule. Allocation will be stra-
tified by site and blocked within strata using random
permuted blocks.
Interventions
Participants in the Advice group will be given advice in a
single session in the fracture clinic, after removal of immo-
bilisation and after consultation with the treating ortho-
paedic specialist. A physiotherapist will advise the
participant to do exercises that involve ankle movement in
non-weight-bearing positions and will explain how to per-
form these exercises and how to progressively reduce the
use of walking aids. The participant will be given a hand-
out that summarises this advice with text and figures.
Participants in the Rehabilitation group will receive
the same advice but will also participate in an exercise
program that is designed, monitored and progressed by
a physiotherapist, with participants encouraged to per-
form a carefully structured exercise program at home.
Three types of exercises will be prescribed: ankle mobi-
lity and strengthening exercises, stepping exercises, and
exercises involving weight-bearing and balancing on the
affected leg. These exercises are routinely prescribed
after immobilisation for ankle fracture and were used in
our recently completed trials [5,6]. Exercise cards have
been developed to standardise the exercises used. Parti-
cipants will also receive gait training and ongoing advice
about returning to usual work and leisure activities. In
keeping with the pragmatic orientation of the trial, par-
ticipating physiotherapists will not be prevented from
administering stretches or manual therapy. The rehabili-
tation program will be provided during two sessions in
week one and in one session from weeks two to four;
further consultations will be at the discretion of the
physiotherapist. Participants will be discharged by their
physiotherapist when they achieve their pre-fracture
function, reach a plateau in their progress, or choose to
discontinue the treatment.
When appropriate, participants in both groups will be
instructed to use ice for pain relief and compression and
elevation for management of swelling. A compression
bandage will be provided if required. Treatments will be
administered by registered physiotherapists who will be
trained to provide the Advice and Rehabilitation inter-
ventions in accordance with the trial protocol.
Outcome assessment
Outcomes will be assessed at baseline and 1, 3 and 6
months later. Outcome data will be obtained from all
randomised participants, in so far as this is possible,
regardless of compliance with the trial protocol. Out-
come measurements will be made by an assessor
blinded to allocation. The participants, as well as phy-
siotherapists and investigators involved in the trial, will
be asked to avoid giving information that could reveal
participant’s allocation to the blinded assessor. After
each assessment the assessor will be asked if he or she
was blinded to allocation and will be asked to guess
which group the participant was allocated to.
At the baseline assessment, demographic and injury
details will be recorded. Classification of fracture sever-
ity (severe or not severe) will be based on the number
of malleoli fractured [20] and the presence of disloca-
tion: bi- or tri-malleolar fractures and any fractures with
dislocation will be classified as severe. The assessor will
classify fracture severity by examining the radiology
entries in the hospital records or, if these are not avail-
able, by examining plain radiographs taken before and
after the fracture reduction. Two psychological scales
will also be used: depression, anxiety and stress will be
measured using the Depression, Anxiety, Stress Scales
21-item [24], and pain catastrophising will be assessed
using the Pain Catastrophising Scale [25].
The primary outcomes will be activity limitation and
quality-adjusted life years. Activity limitation will be
measured with the Lower Extremity Functional Scale
[26] which involves the participant rating the degree of
difficulty in performing 20 functional activities on a 5-
point scale ranging from 0 (’extreme difficulty or unable
to perform activity’) to 4 (’no difficulty’). The scale has
excellent test-retest reliability (intraclass correlation
coefficient (ICC) 0.94), is sensitive to change and has
high internal consistency and construct and concurrent
validity for people with ankle fracture [27]. Quality-
adjusted life years will be measured by the Assessment
of Quality of Life instrument, which is designed to mea-
sure health-related quality of life and to be the descrip-
tive system for a multi-attribute utility instrument. The
Assessment of Quality of Life measures five dimensions:
illness, independent living, social relationships, physical
senses and psychological well-being, all of which have
been shown to be orthogonal and unidimensional [28].
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The Assessment of Quality of Life has been shown to be
internally consistent (alpha = 0.81) and has a compara-
tive fit index of 0.90 [28], and is reliable and more sensi-
tive to health status than other multi-attribute utility
instruments [29].
Secondary outcomes will be the number of days to
pain-free walking, the number of days to return to full
pre-fracture work, return to pre-fracture work and lei-
sure activities, ankle dorsiflexion range of motion, pain,
walking speed, physical activity, and global perceived
effect of treatment (Table 1).
Participants in the Rehabilitation and Advice groups
will complete exercise diaries. Physiotherapists treating
participants in the Rehabilitation group will complete
treatment logs. Participants in the Advice group will be
asked at each assessment if they sought rehabilitation or
physiotherapy services. Participants’ perceptions of the
credibility of the interventions will be determined by
questions administered to all participants at the 6-
month follow-up. At the 6-month assessment, partici-
pants will also be asked open-ended questions about
adverse events.
Economic evaluation
The economic evaluation will consist of cost-effective-
ness and cost-utility analyses. Costs will be measured in
terms of direct costs to the health system and out-of-
pocket costs to the participants over a 6-month period,
and collected in a questionnaire at the 1, 3 and 6 month
follow-up period. From an economic perspective, costs
are measured by resource use. This allows the identifica-
tion of the opportunity cost of resources used, that is,
what could have been achieved had those resources
been allocated to the best alternative use. In this trial
the costs of the interventions and any out-of-pocket
costs incurred by participants will be identified,
measured and valued. Table 2 indicates the type of
resources which will be captured, the sources of data,
and proposed methods of valuation.
The cost-effectiveness analysis will use the Lower
Extremity Functional Scale [26] as a measure of effec-
tiveness. The cost-utility analysis will use the Assess-
ment of Quality of Life instrument as a measure of
utility.
Statistical analysis
Analyses will be conducted by ‘intention-to-treat’ (i.e.
all available data from all randomised participants will
be analysed in the group to which the participant was
allocated). Multiple imputation will be used for missing
data. To test the effects of intervention on continuous
outcomes (activity limitation, quality of life, return to
pre-fracture work and leisure, physical activity (meta-
bolic equivalent minutes per week), ankle range of
motion, pain, walking speed, and global perceived
effect of treatment), between-group comparisons will
be conducted using longitudinal mixed models [30,31].
The independent variables will be a dummy-coded
variable indicating group membership, the time at
which the measurement was taken (four times,
dummy-coded as three variables, with the baseline
time as the referent category), and the three time-by-
group interactions. The effect of rehabilitation at each
of the three follow-up time points is estimated with
the relevant interaction term. The model will incorpo-
rate random intercepts to account for the dependence
of repeated measures. Survival analysis will be used to
estimate between-group differences in days to pain-
free walking and days to return to full pre-fracture
work. Odds ratios will be calculated for physical activ-
ity (level), satisfaction with trial treatment, and adverse
events.
Table 1 Secondary outcome measures assessed at baseline, 1, 3 and 6 months, unless otherwise stated
Outcome Description of assessment
Number of days to pain-free walking Participants will be given a calendar to mark the first day they can walk pain-free for 10 meters to calculate
the number of days elapsed from the day of randomisation to pain-free walking [5].
Number of days to return to full pre-
fracture work
Participants who worked prior to fracture will be given a calendar to mark the first day they return to their
pre-fracture work to calculate the number of days elapsed from the day of randomisation to return to full
pre-fracture work.
Return to pre-fracture work and
leisure
Self-reported percentage return to full pre-fracture work and leisure, where 0% is ‘not participating at all’ and
100% is ‘returned to full level’.
Ankle dorsiflexion range of motion Measured using the weight-bearing lunge method [23] at baseline and 1-month.
Pain Pain on equal weight-bearing and on stair descent measured using a numerical rating scale (0 to 10), where
0 is ‘no pain’ and 10 is ‘worst pain you ever had’, at baseline and 1-month.
Walking speed Unaided walking speed over a 10 m distance using a stop watch at baseline and 1-month.
Physical activity Physical activity will be measured using the International Physical Activity Questionnaire-Short Form [39]. This
questionnaire will be used to classify participants into one of the three activity levels (low, moderate or high)
and calculate the metabolic equivalent (MET) minutes per week.
Global perceived Perceived effect of treatment will be measured on an 11-point scale from -5,
effect of treatment ’vastly worse’, to +5, ‘completely recovered’ at 1, 3 and 6 months.
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In a second analysis, designed to test the influence of
fracture severity on treatment response, additional terms
(fracture severity and the interactions of fracture severity
with the group and time variables) will be entered into
the model. The effect of fracture severity on treatment
response will be determined by examining the interac-
tions between group membership, fracture severity and
the time variables. A similar analysis will test the influ-
ence of participant age and gender on treatment
response. Participants will be divided into women aged
over 50 and others. Again, additional terms (age/gender
and the interactions of age/gender with the group and
time variables) will be entered into the model. The
effect of age/gender on treatment response will be deter-
mined by examining the interactions between group
membership, age/gender and the time variables.
The primary conclusions about effectiveness of rehabi-
litation will be based on between-group comparisons of
activity limitation and quality of life at 3 months. The
primary conclusions about whether fracture severity and
age and gender influence the effectiveness of interven-
tion will be based on the interactions between these fac-
tors and effects of rehabilitation for activity limitation
and quality of life at 3 months.
The economic evaluation will examine differences
between participants in the Rehabilitation and Advice
groups in terms of costs incurred and changes in per-
ceived activity limitation (cost-effectiveness analysis) or
utility gained (cost-utility analysis). The incremental
cost-effectiveness (utility) ratio (ICER) will be calculated
as: ICER = (CR - CA)/(UR - UA), where C is average
cost, U is the average effectiveness or utility score, and
subscripts R and A denote the Rehabilitation and Advice
arms. The Rehabilitation program can be said to be
cost-effective relative to Advice about exercise if it (a)
produces less activity limitation or greater utility at a
lower cost or (b) the cost per activity limitation avoided
or per quality-adjusted life years gained (i.e. the incre-
mental cost-effectiveness (utility) ratio) is less than some
threshold value (e.g. $50,000). Bias-corrected boot-
strapped estimates (1,000 replications) will be used to
test for the difference in mean costs and to obtain 95%
confidence intervals for between-group differences in
mean costs. Between-group differences in utilisation will
be tested using Fisher’s exact test. Sensitivity analyses
will be undertaken to explore the robustness and validity
of the results. Both costs and outcomes will be varied in
line with results from similar studies reported in the lit-
erature and the upper and lower limits of estimates
from this trial.
To establish the predictors of outcome after ankle
fracture, univariate linear regression will be used to
examine the relationship between seven baseline vari-
ables (fracture severity, pain, ankle range of motion,
mobility, depression, anxiety and stress, and pain cata-
strophising) and activity limitation at 1-month and 6
months after removal of immobilisation. A multivariate
linear prediction model will be developed using methods
described by Harrell [32].
Sample size
A sample of 76 participants (38 per group) would pro-
vide an 80% probability of detecting a difference
between the group means of 10 points on the 80-point
Lower Extremity Functional Scale (assuming a SD of 15
points, based on data from our recently completed trials
[5,6]). This sample size will also provide 80% probability
of detecting a difference between the group means of
2.75 points on the 45-point Assessment of Quality of
Life scale (assuming a SD of 4 points, based on data
from our recently completed trial [5]). Effects smaller
than these are unlikely to be considered clinically worth-
while. In our calculations we assumed an alpha of 0.05,
and we allowed for 5% loss to follow-up. We conserva-
tively ignored the extra precision conferred by the longi-
tudinal design.
In order to power the trial for analyses of the interac-
tions with fracture severity and age/gender of partici-
pants we need to inflate the sample size by a factor of 2
+ k + 1/k, where k is the sub-group ratio. We anticipate
the sub-group ratio for both severe: less severe fracture
and women aged over 50: others is ~1:2 (based on our
Table 2 Assessment of resource use





Salary rates plus on-costs for physiotherapists using published prices
Equipment Questionnaires
at 1, 3, 6 months
Manufacturer’s price (depreciated over 3 years)
Medication, visits to general practitioners and other health
professionals, hospitalisation, visits to emergency
department
Questionnaires
at 1, 3, 6 months
Published prices (e.g. Pharmaceutical Benefits Scheme and Medicare
Benefits Schedule reimbursement) and/or actual costs to
participants
Visits to community services or alternative or
complementary health practitioners
Questionnaires
at 1, 3, 6 months
Actual costs to participants
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recently completed studies [5,6]). Thus, a sample of 72 ×
4.5 = 342 participants (171 per group) will be recruited.
Ethics
The trial will be conducted in Sydney, Australia follow-
ing the principles of the Helsinki declaration and in
accordance with the Australia’s National Statement on
Ethical Conduct in Human Research. Participants will
receive information about the study protocol before pro-
viding their written consent to be in the study. All data
collected will be confidential. This study has ethical
approval from the Hawkesbury Human Ethics Commit-
tee of Northern Sydney Central Coast Health, Sydney,
Australia, and site specific approvals from the ethics
committee of each participating site (Prince of Wales
Hospital, Ryde Hospital, Royal North Shore Hospital
and Royal Prince Alfred Hospital). This trial is registered
at the Australian New Zealand Clinical Trials Registry
ACTRN12610000979055.
Discussion
The EXACT trial will provide evidence on the effective-
ness of rehabilitation after ankle fracture. Participants
receiving the Rehabilitation intervention will receive an
individually tailored and exercise-based physiotherapy
program and participants receiving the Advice interven-
tion will not, because the intent is to compare the
effects of these two alternatives when they are adminis-
tered as usually applied in the clinic. We will not match
the number of treatment sessions for the Advice group
because, given the pragmatic orientation of the trial, it is
more important to replicate current clinical practice. A
pragmatic trial design [33,34] was chosen to enable easy
translation of the research findings into clinical practice.
Our trial incorporates features that minimise bias,
including concealed random allocation and blinded
data analysis [35]. Blinding of outcome assessment
may be particularly important in exercise trials such as
ours, where the blinding of participants and therapists
is not possible [36]. The primary outcomes (activity
limitation, quality-adjusted life years etc) will be self-
reported by participants who are not blinded. However
the assessors who elicit primary outcome data, and
who collect secondary outcome data such as ankle dor-
siflexion range of motion and walking speed, will be
unaware of group allocation. Consequently the assess-
ment of outcome is partially blinded. Procedures
recently suggested to achieve blinding in pragmatic
physiotherapy trials will be used in our trial, including
asking participants not to reveal their group allocation
to assessors when booking follow-up appointments and
at the start of each assessment, and restricting assessor
access to trial data which indicates group allocation
(computer files will be password protected and
paperwork will be in a separate locked filing cabinet)
[37]. We will also confirm the success of assessor
blinding by asking the assessor if he or she was
blinded to allocation and to guess which group the
participant was allocated to after each assessment.
The sample size will be large enough to provide pre-
cise estimates of treatment effects. Importantly, the trial
is adequately powered to investigate whether the effects
of rehabilitation differ across sub-groups of participants
[38]. In our trial we will determine if treatment effects
are influenced by fracture severity and by the age and
gender of participants.
Several strategies will be implemented in order to
ensure data quality. Assessors and treating physiothera-
pists will be adequately trained before they work on the
trial. Compliance with the trial protocol will be closely
monitored by an on-site associate investigator. Data
forms and processing will be regularly scrutinised for
accuracy and completeness. All data entry will be dou-
ble-checked for accuracy. After the trial, the security of
randomisation will be evaluated by comparing actual
group allocations with a record of the randomisation
schedule.
Recruitment commenced in December 2010 and trial
completion (follow-up of all participants) is planned for
April 2013. The results are expected to be available by
the end of 2013.
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